Clin2
NCT07795125Possibly a fitNot yet recruiting

Migraine medication for endometriosis pain

EndometriosisEndometriosis-related Pain

Treatments studied

Part of Women’s health & pregnancy clinical trials.

This study tests a non-hormonal medication (rinegepant, used for migraines) to see if it can reduce endometriosis pain. It involves taking the medication daily and keeping a pain diary for 12 weeks.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
132 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are a woman between 18 and 45 years old
  • Your endometriosis was confirmed by a surgical biopsy within the last 3 to 6 months
  • You have moderate to severe pain from endometriosis
  • You are using effective birth control and are willing to continue it for 12 weeks
  • You are not pregnant, breastfeeding, or menopausal
  • You do not have heart disease, stroke history, uncontrolled high blood pressure, diabetes, severe kidney or liver disease, or allergy to rimegepant

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07100782Recruiting· Phase 3
Estrogen & pain trial for endometriosis pelvic pain

This study tests whether a drug called relugolix CT can reduce pelvic pain from endometriosis. You'll have brain scans and pain tests to measure how your body processes pain. It might help if other treatments haven't worked well.

Ann Arbor, Michigan
NCT07318688Recruiting· Phase 3
Testing HMI-115 for endometriosis pain

This trial tests an experimental drug called HMI-115 to see if it reduces pain from endometriosis. If you have moderate to severe period pain and non-period pain, and you have a surgical diagnosis, you may be able to join.

Beijing, Beijing Municipality
NCT06963177Recruiting· Phase 2
Study of GenSci048 for endometriosis pain

This trial tests a new drug called GenSci048 to see if it can reduce moderate to severe pain caused by endometriosis. It might be an option if you have regular periods and are willing to switch to only the pain relievers allowed in the study.

Beijing, Beijing Municipality
NCT06161805Recruiting· Phase 3
Esketamine for chronic pain from endometriosis

This trial tests if esketamine, a nasal spray, can reduce chronic pelvic pain in women with endometriosis that hasn't improved with standard painkillers. You may qualify if you have severe pain and are scheduled for endometriosis surgery.

Delft
NCT07440043Not yet recruiting
Relugolix for pain caused by endometriosis

This trial is testing a medicine called Relugolix to see how well it relieves pain from endometriosis, a condition where tissue similar to the womb lining grows outside the womb. It might help people with moderate to severe pain that hasn't improved with other treatments.

NCT06952296Not yet recruiting
Dydrogesterone for endometriosis-related pain

This study tests a hormone pill called dydrogesterone (brand name Duphaston) for treating endometriosis-related pain. You'll take the pill for part of your menstrual cycle, and the study will track whether it helps reduce your pain.

Hear when a new Endometriosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.